Functional and protein chemical characterization of the N-terminal domain of the rat corticotropin-releasing factor receptor 1

被引:36
作者
Hofmann, BA [1 ]
Sydow, S [1 ]
Jahn, O [1 ]
Van Werven, L [1 ]
Liepold, T [1 ]
Eckart, K [1 ]
Spiess, J [1 ]
机构
[1] Max Planck Inst Expt Med, Dept Mol Neuroendocrinol, D-37073 Gottingen, Germany
关键词
corticotropin-releasing factor; CRF receptor; human embryonic kidney cells; scintillation proximity assay; amino-terminal domain; binding domain; disulfide bond structure; glycosylation structure;
D O I
10.1110/ps.12101
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Rat corticotropin-releasing factor receptor 1 (rCRFR 1) was produced either in transfected HEK 293 cells as a complex glycosylated protein or in the presence of the mannosidase I inhibitor kifunensine as a high mannose glycosylated protein. The altered glycosylation did not influence the biological function of rCRFR1 as demonstrated by competitive binding of rat urocortin (rUcn) or human/rat corticotropin-releasing factor (h/rCRF) and agonist-induced CAMP accumulation. The low production rate of the N-terminal domain of rCRFR1 (rCRFR1-NT) by transfected HEK 293 cells, was increased by a factor of 100 in the presence of kifunensine. The product, rCRFR1-NT-Kif, bound rUen specifically (K-D = 27 nM) and astressin (K-I = 60 nM). This affinity was 10-fold lower than the affinity of full length rCRFR1. However, it was sufficiently high for rCRFR1-NT-Kif to serve as a model for the N-terminal domain of rCRFR1. With protein fragmentation, Edman degradation, and mass spectrometric analysis, evidence was found for the signal peptide cleavage site C-terminally to Thr(23) and three disulfide bridges between precursor residues 30 and 54, 44 and 87, and 68 and 102. Of all putative N-glycogylation sites in positions 32, 38, 45, 78, 90, and 98, all Asn residues except for Asn(32) were glycosylated to a significant extent. No O-glycosylation was observed.
引用
收藏
页码:2050 / 2062
页数:13
相关论文
共 62 条
[31]   Structure and function of the ovine type 1 corticotropin releasing factor receptor (CRF1) and a carboxyl-terminal variant [J].
Myers, DA ;
Trinh, JV ;
Myers, TR .
MOLECULAR AND CELLULAR ENDOCRINOLOGY, 1998, 144 (1-2) :21-35
[32]   Identification of prokaryotic and eukaryotic signal peptides and prediction of their cleavage sites [J].
Nielsen, H ;
Engelbrecht, J ;
Brunak, S ;
vonHeijne, G .
PROTEIN ENGINEERING, 1997, 10 (01) :1-6
[33]   DISULFIDE BRIDGES IN EXTRACELLULAR DOMAINS OF ANGIOTENSIN-II RECEPTOR-TYPE I-A [J].
OHYAMA, K ;
YAMANO, Y ;
SANO, T ;
NAKAGOMI, Y ;
HAMAKUBO, T ;
MORISHIMA, I ;
INAGAMI, T .
REGULATORY PEPTIDES, 1995, 57 (02) :141-147
[34]  
Palchaudhuri MR, 1999, J NEUROENDOCRINOL, V11, P419
[35]   Corticotropin-releasing factor receptor type 1 from Tupaia belangeri -: Cloning, functional expression and tissue distribution [J].
Palchaudhuri, MR ;
Wille, S ;
Mevenkamp, G ;
Spiess, J ;
Fuchs, E ;
Dautzenberg, FM .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 1998, 258 (01) :78-84
[36]   A DISULFIDE BOND BETWEEN CONSERVED EXTRACELLULAR CYSTEINES IN THE THYROTROPIN-RELEASING-HORMONE RECEPTOR IS CRITICAL FOR BINDING [J].
PERLMAN, JH ;
WANG, W ;
NUSSENZVEIG, DR ;
GERSHENGORN, MC .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (42) :24682-24685
[37]   IDENTIFICATION OF A 2ND CORTICOTROPIN-RELEASING FACTOR-RECEPTOR GENE AND CHARACTERIZATION OF A CDNA EXPRESSED IN HEART [J].
PERRIN, M ;
DONALDSON, C ;
CHEN, RP ;
BLOUNT, A ;
BERGGREN, T ;
BILEZIKJIAN, L ;
SAWCHENKO, P ;
VALE, W .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (07) :2969-2973
[38]   CLONING AND FUNCTIONAL EXPRESSION OF A RAT-BRAIN CORTICOTROPIN-RELEASING FACTOR (CRF) RECEPTOR [J].
PERRIN, MH ;
DONALDSON, CJ ;
CHEN, R ;
LEWIS, KA ;
VALE, WW .
ENDOCRINOLOGY, 1993, 133 (06) :3058-3061
[39]   The first extracellular domain of corticotropin releasing factor-R1 contains major binding determinants for urocortin and astressin [J].
Perrin, MH ;
Sutton, S ;
Bain, DL ;
Berggren, WT ;
Vale, WW .
ENDOCRINOLOGY, 1998, 139 (02) :566-570
[40]  
Perrin MH, 1999, J PHARMACOL EXP THER, V288, P729